Strengthening the bones in primary biliary cirrhosis.
作者信息
Angulo Paul
机构信息
Division of Digestive Diseases and Nutrition, University of Kentucky Medical Center, Lexington, KY.
出版信息
Hepatology. 2013 Dec;58(6):1871-3. doi: 10.1002/hep.26696. Epub 2013 Oct 17.
Abstract
摘要
相似文献
1
Strengthening the bones in primary biliary cirrhosis.增强原发性胆汁性肝硬化患者的骨骼强度
Hepatology. 2013 Dec;58(6):1871-3. doi: 10.1002/hep.26696. Epub 2013 Oct 17.
2
Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis.比较原发性胆汁性肝硬化患者每月伊班膦酸盐和每周阿仑膦酸盐治疗骨质疏松症的随机试验。
Hepatology. 2013 Dec;58(6):2070-8. doi: 10.1002/hep.26466. Epub 2013 Oct 29.
3
Postmenopausal Osteoporosis.绝经后骨质疏松症
N Engl J Med. 2016 May 26;374(21):2096. doi: 10.1056/NEJMc1602599.
4
Postmenopausal Osteoporosis.绝经后骨质疏松症
N Engl J Med. 2016 May 26;374(21):2095-6. doi: 10.1056/NEJMc1602599.
5
Postmenopausal Osteoporosis.绝经后骨质疏松症
N Engl J Med. 2016 May 26;374(21):2095. doi: 10.1056/NEJMc1602599.
6
Postmenopausal Osteoporosis.绝经后骨质疏松症
N Engl J Med. 2016 May 26;374(21):2096-7. doi: 10.1056/NEJMc1602599.
7
Estrogen and postmenopausal osteoporosis.雌激素与绝经后骨质疏松症
Ann Intern Med. 1993 Jan 15;118(2):155; author reply 156. doi: 10.7326/0003-4819-118-2-199301150-00016.
8
Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study.雷洛昔芬可改善原发性胆汁性肝硬化骨质疏松女性的骨量：一项试点研究的结果。
Liver Int. 2005 Feb;25(1):117-21. doi: 10.1111/j.1478-3231.2005.01026.x.
9
Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment.原发性胆汁性肝硬化中的骨质疏松症：发病机制与治疗
Clin Liver Dis. 2008 May;12(2):407-24; x. doi: 10.1016/j.cld.2008.02.005.
10
The treatment of postmenopausal osteoporosis.
N Engl J Med. 1995 Nov 30;333(22):1495-6. doi: 10.1056/NEJM199511303332209.
引用本文的文献
1
Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment.肝性骨营养不良：肝细胞疾病中骨质流失的机制及帕米膦酸治疗的效果
Clinics (Sao Paulo). 2017 Apr;72(4):231-237. doi: 10.6061/clinics/2017(04)07.
2
Primary biliary cirrhosis degree assessment by acoustic radiation force impulse imaging and hepatic fibrosis indicators.通过声辐射力脉冲成像和肝纤维化指标评估原发性胆汁性肝硬化程度
World J Gastroenterol. 2016 Jun 14;22(22):5276-84. doi: 10.3748/wjg.v22.i22.5276.
本文引用的文献
1
Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis.比较原发性胆汁性肝硬化患者每月伊班膦酸盐和每周阿仑膦酸盐治疗骨质疏松症的随机试验。
Hepatology. 2013 Dec;58(6):2070-8. doi: 10.1002/hep.26466. Epub 2013 Oct 29.
2
Osteoporosis in men: an Endocrine Society clinical practice guideline.男性骨质疏松症：内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2012 Jun;97(6):1802-22. doi: 10.1210/jc.2011-3045.
3
Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis.低骨量和胆汁淤积严重程度影响原发性胆汁性肝硬化患者的骨折风险。
Gastroenterology. 2010 Jun;138(7):2348-56. doi: 10.1053/j.gastro.2010.02.016. Epub 2010 Feb 20.
4
Primary biliary cirrhosis and osteoporosis: a case-control study.原发性胆汁性肝硬化与骨质疏松症：一项病例对照研究。
J Bone Miner Metab. 2008;26(4):379-84. doi: 10.1007/s00774-007-0833-1. Epub 2008 Jul 4.
5
Fracture risk in people with primary biliary cirrhosis: a population-based cohort study.原发性胆汁性肝硬化患者的骨折风险：一项基于人群的队列研究。
Gastroenterology. 2006 Dec;131(6):1752-7. doi: 10.1053/j.gastro.2006.09.012. Epub 2006 Sep 8.
6
Bone mineral density before and after OLT: long-term follow-up and predictive factors.肝移植前后的骨矿物质密度：长期随访及预测因素
Liver Transpl. 2006 Sep;12(9):1390-402. doi: 10.1002/lt.20874.
7
Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial.阿仑膦酸盐可改善原发性胆汁性肝硬化患者的骨矿物质密度：一项随机安慰剂对照试验。
Hepatology. 2005 Oct;42(4):762-71. doi: 10.1002/hep.20866.
8
Is osteoporosis a peculiar association with primary biliary cirrhosis?骨质疏松症与原发性胆汁性肝硬化之间是否存在特殊关联？
World J Gastroenterol. 2005 Sep 14;11(34):5347-50. doi: 10.3748/wjg.v11.i34.5347.
9
Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.胆汁淤积的严重程度和晚期组织学分期而非绝经状态是原发性胆汁性肝硬化骨质疏松的主要危险因素。
J Hepatol. 2005 Apr;42(4):573-7. doi: 10.1016/j.jhep.2004.11.035. Epub 2005 Jan 13.
10
Assessment of fracture risk.骨折风险评估。
Osteoporos Int. 2005 Jun;16(6):581-9. doi: 10.1007/s00198-004-1780-5. Epub 2004 Dec 23.
Zotero 插件